Scientists May Have Found a Possible Cure for Acute Leukemia in Base Edited T-Cells
https://pixabay.com/en/children-road-distant-supportive-1149671/

Scientists May Have Found a Possible Cure for Acute Leukemia in Base Edited T-Cells

Leukemia is cancer that begins in the bone marrow and involves abnormal white blood cells (WCB) from lymphatic tissues and bone marrow. Scientists have new theories as to why certain…

Continue Reading Scientists May Have Found a Possible Cure for Acute Leukemia in Base Edited T-Cells
He Survived Acute Lymphoblastic Leukemia. Now He’s Pursuing Medicine to Help Kids Like Himself.
source: shutterstock.com

He Survived Acute Lymphoblastic Leukemia. Now He’s Pursuing Medicine to Help Kids Like Himself.

  When he thinks about his ideal career, Jaziel Olmeda imagines being in a sparkling clean, white hospital ward. His goal: to help children going through pediatric cancer diagnoses. To…

Continue Reading He Survived Acute Lymphoblastic Leukemia. Now He’s Pursuing Medicine to Help Kids Like Himself.
New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant
source: pixabay.com

New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant

  Omisirge (omidubicel) is the first allogeneic (from a donor) product for SCT that has been the recipient of FDA approval. The FDA's nod moves Omisirge into the realm of…

Continue Reading New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant
Advanced Leukemia: Test of Oral Revumenib Brought Impressive Results
source: pixabay.com

Advanced Leukemia: Test of Oral Revumenib Brought Impressive Results

  For patients with refractory or relapsed KMT2A rearrangement or NPM1-mutations, the AUGMENT 101 study of the investigational menin inhibitor revumenib yielded impressive results. According to an article in MedicalXpress,…

Continue Reading Advanced Leukemia: Test of Oral Revumenib Brought Impressive Results
Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)
192635 / Pixabay

Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)

  KMT2A rearrangements—a DNA fault—lead to treatment-resistant acute lymphoblastic leukemia (ALL) in infants. While around 50% of children with KMT2A rearrangements respond well to intensive chemotherapy, the remaining 50% do…

Continue Reading Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)
Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)
Photo: Todd Druley, Mission Bio

Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)

Don't forget to read Part 1 of our interview, where Todd discusses what acute lymphoblastic leukemia (ALL) is and why it is so important to raise awareness for ALL and other cancers. Today,…

Continue Reading Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 2)
Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)
Photo: Todd Druley, Mission Bio

Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)

Did you know that September is Childhood Cancer Awareness Month? Although September has just passed, it is still important to raise awareness of the many different forms of childhood cancer…

Continue Reading Mapping Acute Lymphoblastic Leukemia (ALL) Subtypes: An Interview with Todd Druley of Mission Bio (Pt. 1)

ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity

  Dr. Cecilia Chung and associates at the Vanderbilt University’s Medical Center conducted a study published recently in MedPage Today. Results showed that patients who had inflammatory disorders, as well…

Continue Reading ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity
FDA Orphan Drug Designation for AML and Pancreatic Cancer Treatment Possibly More Effective Than Chemotherapy
source: pixabay.com

FDA Orphan Drug Designation for AML and Pancreatic Cancer Treatment Possibly More Effective Than Chemotherapy

The FDA has just provided AB001 the Orphan Drug designation for both acute myeloid leukemia (AML) and pancreatic cancer. This small molecule was developed by Vopec Pharmaceuticals and Agastiya Biotech.…

Continue Reading FDA Orphan Drug Designation for AML and Pancreatic Cancer Treatment Possibly More Effective Than Chemotherapy

A Mother’s Thoughts When Her Two-Year-Old Daughter Was Diagnosed with Acute Lymphoblastic Leukemia

Imagine the highs and lows that accompany the doctor’s announcement that your sweet, innocent two-year-old daughter has leukemia. The good news is that your daughter has the type of leukemia…

Continue Reading A Mother’s Thoughts When Her Two-Year-Old Daughter Was Diagnosed with Acute Lymphoblastic Leukemia
First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia
https://unsplash.com/photos/tV-RX0beDp8

First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia

Each year, an estimated 11,000 people across the globe are diagnosed with relapsed or refractory (R/R) T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (LBL). However, there is only one…

Continue Reading First Patient Dosed in WU-CART-007 Trial for Acute Lymphoblastic Leukemia
Compassion: The Staff at Cardinal Glennon’s Hospital Supported Joey and His Nephew’s Fight Against Acute Lymphoblastic Leukemia
source: pixabay.com

Compassion: The Staff at Cardinal Glennon’s Hospital Supported Joey and His Nephew’s Fight Against Acute Lymphoblastic Leukemia

Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…

Continue Reading Compassion: The Staff at Cardinal Glennon’s Hospital Supported Joey and His Nephew’s Fight Against Acute Lymphoblastic Leukemia
ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
source: pixabay.com

ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients

According to a story from Financial Buzz, the precision oncology company Notable has recently announced that it has opened enrollment for a new observational clinical trial that will focus on…

Continue Reading ICYMI: An Observational Blood Cancer Study is Starting to Recruit Patients
A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
source: pixabay.com

A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling

The Platform Notable's automated technology platform was created to help predict which patients would respond better to which therapies. As no patient is the same, this study is paramount. Notable…

Continue Reading A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling

Donors are Needed Due To A Shortage of Platelets That Threatens A Young Child’s Life

Tahnee Hamilton was recently interviewed by KSL-TV about her young child, Avery, who was diagnosed less than a year ago with T Cell Acute Lymphoblastic Leukemia. About Veno-Occlusive disease (VOD) Avery…

Continue Reading Donors are Needed Due To A Shortage of Platelets That Threatens A Young Child’s Life

Pediatric Cancer and the 70th Anniversary of the Leukemia & Lymphoma Society

  When the Leukemia & Lymphoma Society (LLS) was founded in 1949 by a family in memory of their sixteen-year-old son, cancer was considered a hopeless condition. As noted recently…

Continue Reading Pediatric Cancer and the 70th Anniversary of the Leukemia & Lymphoma Society